Arrowhead Pharmaceuticals Inc (ARWR)
21.45
-1.84
(-7.90%)
USD |
NASDAQ |
Apr 25, 12:34
Arrowhead Pharmaceuticals Total Assets (Quarterly): 626.29M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 626.29M |
| September 30, 2023 | 765.55M |
| June 30, 2023 | 795.86M |
| March 31, 2023 | 891.31M |
| December 31, 2022 | 891.49M |
| September 30, 2022 | 691.94M |
| June 30, 2022 | 751.78M |
| March 31, 2022 | 703.58M |
| December 31, 2021 | 638.54M |
| September 30, 2021 | 710.15M |
| June 30, 2021 | 734.93M |
| March 31, 2021 | 756.80M |
| December 31, 2020 | 499.25M |
| September 30, 2020 | 522.50M |
| June 30, 2020 | 555.73M |
| March 31, 2020 | 561.08M |
| December 31, 2019 | 587.60M |
| September 30, 2019 | 349.85M |
| June 30, 2019 | 336.83M |
| March 31, 2019 | 333.94M |
| December 31, 2018 | 340.95M |
| September 30, 2018 | 111.61M |
| June 30, 2018 | 112.90M |
| March 31, 2018 | 127.00M |
| December 31, 2017 | 88.22M |
| Date | Value |
|---|---|
| September 30, 2017 | 104.02M |
| June 30, 2017 | 115.08M |
| March 31, 2017 | 126.87M |
| December 31, 2016 | 144.26M |
| September 30, 2016 | 128.18M |
| June 30, 2016 | 85.53M |
| March 31, 2016 | 94.61M |
| December 31, 2015 | 111.38M |
| September 30, 2015 | 132.27M |
| June 30, 2015 | 145.19M |
| March 31, 2015 | 162.38M |
| December 31, 2014 | 162.14M |
| September 30, 2014 | 182.82M |
| June 30, 2014 | 196.62M |
| March 31, 2014 | 202.64M |
| December 31, 2013 | 92.69M |
| September 30, 2013 | 37.33M |
| June 30, 2013 | 41.49M |
| March 31, 2013 | 12.42M |
| December 31, 2012 | 15.23M |
| September 30, 2012 | 16.53M |
| June 30, 2012 | 16.49M |
| March 31, 2012 | 20.08M |
| December 31, 2011 | 23.06M |
| September 30, 2011 | 15.89M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
336.83M
Minimum
Jun 2019
891.49M
Maximum
Dec 2022
651.11M
Average
691.94M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 640.55M |
| Viking Therapeutics Inc | 368.49M |
| Akero Therapeutics Inc | 580.27M |
| 89bio Inc | 596.27M |
| Sagimet Biosciences Inc | 96.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 452.57M |
| Shareholders Equity (Quarterly) | 160.41M |
| Current Ratio | 3.733 |